Previous close | 220.33 |
Open | 218.73 |
Bid | 200.00 x 800 |
Ask | 217.70 x 900 |
Day's range | 213.91 - 219.06 |
52-week range | 191.97 - 238.47 |
Volume | |
Avg. volume | 576,222 |
Market cap | 18.5B |
Beta (5Y monthly) | 1.04 |
PE ratio (TTM) | 40.95 |
EPS (TTM) | 5.33 |
Earnings date | 01 Aug 2024 |
Forward dividend & yield | 2.88 (1.31%) |
Ex-dividend date | 29 Aug 2024 |
1y target est | 253.14 |
Labcorp has reached an agreement to purchase select outreach laboratory services from Ballad Health.
The main point of investing for the long term is to make money. Better yet, you'd like to see the share price move up...
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that members of the executive management team will participate in a presentation at the Baird 2024 Global Healthcare Conference on Tuesday, September 10, at 3:10 p.m. ET.